XML 220 R157.htm IDEA: XBRL DOCUMENT v3.20.4
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Statement of Cash Flows) (Details 3) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash Flows from Operating Activities                      
Net income $ 177 $ (140) $ (539) $ 2,036 $ 463 $ 543 $ 492 $ 395 $ 1,534 $ 1,893 $ 2,098
Gain (Loss) on Disposition of Business before Affinity Payment                   313  
Net Cash Provided by (Used in) Operating Activities                 4,623 2,341 2,597
Proceeds from sales                 1,708 242 435
Available-for-Sale securities:                      
Maturities, sinking fund payments and calls                 9,554 8,202 6,738
Purchases                 (13,525) (11,911) (8,346)
Payments to Acquire Other Investments                 (284) (288) (653)
Purchase of land, buildings, equipment and software                 (147) (143) (162)
Proceeds from Divestiture of Businesses                   1,100  
Other, net                 17 (115) (56)
Net cash (used in) provided by investing activities                 (2,894) (3,234) (587)
Cash Flows from Financing Activities                      
Dividends paid to shareholders                 (497) (504) (506)
Repurchase of common shares                 (1,441) (1,943) (1,630)
Cash paid for purchased options with deferred premiums                 (211) (396) (228)
Issuance of long-term debt, net of issuance costs                 496 497  
Repayments of long-term debt                 (762) (313) (13)
Exercise of stock options                 3 3 2
Other, net                 (10) 1 3
Net cash provided by (used in) financing activities                 952 1,214 (1,263)
Net increase (decrease) in cash and cash equivalents                 2,690 330 739
Supplemental Disclosures:                      
Income taxes paid (received), net                 236 609 538
Ameriprise Financial, Inc:                      
Cash Flows from Operating Activities                      
Net income                 1,534 1,893 2,098
Equity in earnings of subsidiaries                 (1,727) (2,072) (2,333)
Dividends received from subsidiaries                 2,018 2,721 2,093
Gain (Loss) on Disposition of Business before Affinity Payment                 0 313  
Other operating activities, primarily with subsidiaries                 282 596 57
Net Cash Provided by (Used in) Operating Activities                 2,107 2,825 1,915
Proceeds from sales                 922 0 0
Available-for-Sale securities:                      
Maturities, sinking fund payments and calls                 161 204 94
Purchases                 (15) (1,153) (222)
Proceeds from sale of other investments                 0 6 0
Payments to Acquire Other Investments                 (12) (12)  
Purchase of land, buildings, equipment and software                 (54) (42) (62)
Proceeds from Divestiture of Businesses                 0 1,138  
Contributions to subsidiaries                 (416) (368) (73)
Return of capital from subsidiaries                 131 18 454
Repayment of loans from subsidiaries                 3,288 2,468 1,623
Issuance of loans to subsidiaries                 (3,174) (2,457) (1,768)
Acquisition of surplus loans to subsidiaries                 (500) 0 0
Proceeds from Sale of Productive Assets                 (2) 0 0
Other, net                 0 (65) 2
Net cash (used in) provided by investing activities                 333 (263) 48
Cash Flows from Financing Activities                      
Dividends paid to shareholders                 (497) (504) (506)
Repurchase of common shares                 (1,441) (1,943) (1,630)
Cash paid for purchased options with deferred premiums                 0 (107) (20)
Issuance of long-term debt, net of issuance costs                 496 497  
Repayments of long-term debt                 (762) (313) (13)
Borrowings from subsidiaries                 871 132 472
Repayments of borrowings from subsidiaries                 (751) (79) (273)
Exercise of stock options                 3 3 2
Other, net                 (18) 6 (13)
Net cash provided by (used in) financing activities                 (2,099) (2,308) (1,981)
Net increase (decrease) in cash and cash equivalents                 341 254 (18)
Cash and cash equivalents at beginning of period       $ 730       $ 476 730 476 494
Cash and cash equivalents at end of period $ 1,071       $ 730       1,071 730 476
Supplemental Disclosures:                      
Interest paid on debt                 107 123 126
Income taxes paid (received), net                 26 (109) (27)
Non-cash dividends from subsidiaries                 $ 0 $ 81 $ 195